{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:36Z","timestamp":1790700216211,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006392","name":"Centre Hospitalier Universitaire Vaudois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000221","name":"Canadian Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jcf.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:54:50Z","timestamp":1565337290000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-1679","authenticated-orcid":false,"given":"Angela","family":"Koutsokera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Corriveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-8060","authenticated-orcid":false,"given":"Adele","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-2169","authenticated-orcid":false,"given":"Kieran","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1513\/pats.200908-086AL","article-title":"Allergic bronchopulmonary aspergillosis","volume":"7","author":"Patterson","year":"2010","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0010","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: cystic fibrosis foundation consensus conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2213-2600(13)70025-0","article-title":"Management of comorbidities in older patients with cystic fibrosis","volume":"1","author":"Plant","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2019.07.011_bb0020","author":"CF Foundation Registry"},{"issue":"8","key":"10.1016\/j.jcf.2019.07.011_bb0025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thorax.57.8.742","article-title":"\u201cCF asthma\u201d: what is it and what do we do about it?","volume":"57","author":"Balfour-Lynn","year":"2002","journal-title":"Thorax."},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ppul.22934","article-title":"Asthma and cystic fibrosis: a tangled web","volume":"49","author":"Kent","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2019.07.011_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2","article-title":"Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada","volume":"28","author":"Morgan","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-0496(199708)24:2<147::AID-PPUL15>3.0.CO;2-2","article-title":"International practice patterns by age and severity of lung disease in cystic fibrosis: data from the epidemiologic registry of cystic fibrosis (ERCF)","volume":"24","author":"Koch","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2019.07.011_bb0045","article-title":"Omalizumab for asthma in adults and children","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jcf.2019.07.011_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.07.011_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JAA.S156049","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"11","author":"Ashkenazi","year":"2018","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ppul.23612","article-title":"Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients","volume":"52","author":"Nove-Josserand","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.07.011_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.rmed.2017.11.007","article-title":"Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis","volume":"133","author":"Perisson","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2019.07.011_bb0075","unstructured":"Novartis. An exploratory study to assess multiple doses of Omalizumab in patients with cystic fibrosis complicated by acute bronchopulmonary aspergillosis (ABPA). Clinicaltrials.gov (www.clinicaltrials.gov) (accessed 21\/01\/2013) 2008:ClinicalTrials.gov Identifier: NCT00787917. [CRS: 5500100000010742]."},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0080","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Jat","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","article-title":"Reference ranges for spirometry across all ages: a new approach","volume":"177","author":"Stanojevic","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.07.011_bb0090","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1038\/srep08191","article-title":"Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis","volume":"5","author":"Lai","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"van der Ent","year":"2007","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.jcf.2019.07.011_bb0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11882-011-0217-4","article-title":"Severe asthma with fungal sensitization","volume":"11","author":"Agarwal","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.jcf.2019.07.011_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MCP.0000000000000129","article-title":"Allergic fungal airway disease: pathophysiologic and diagnostic considerations","volume":"21","author":"Woolnough","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.jcf.2019.07.011_bb0115","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1060028015624204","article-title":"Omalizumab treatment for allergic bronchopulmonary aspergillosis in cystic fibrosis","author":"Emiralioglu","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jcf.2019.07.011_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753465814547517","article-title":"Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"8","author":"Lehmann","year":"2014","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1016\/j.jcf.2019.07.011_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a prospective real-world study","volume":"7","author":"Casale","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.jcf.2019.07.011_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.alit.2017.08.003","article-title":"Long-term course of serum total and free IgE levels in severe asthma patients treated with omalizumab","volume":"67","author":"Gon","year":"2018","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.jcf.2019.07.011_bb0135","first-page":"88","article-title":"Management of patients with cystic fibrosis and allergic bronchopulmonary Aspergillosis using anti-immunoglobulin E therapy (omalizumab)","volume":"17","author":"ElMallah","year":"2012","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919931930832X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919931930832X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:29Z","timestamp":1761601289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919931930832X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S156919931930832X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.07.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}